Skip to content
Back to BDC

Belden Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
11
Purchases
0
Sales
11
Purchase value
$0.00
Sale value
$2.93M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Brian LieserEVP - Chief Comm. Officer
4Rule 10b5-1 plan disclosed
Filed Sep 16, 2026Period of report Sep 15, 20260001193125-26-393292
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 15, 2026
Common StockF11,900$114.39$217.34K31,144Direct
Filing footnotes · 2
  1. F1The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Lieser on August 11, 2025.
  2. F2Represents the balance of shares of Belden Inc. common stock held in the Belden Retirement Savings Plan as of the date of this filing.
Open on SEC EDGAR
Brian LieserEVP - Chief Comm. Officer
4Rule 10b5-1 plan disclosed
Filed Apr 14, 2026Period of report Apr 14, 20260001193125-26-155165
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 14, 2026
Common StockF12,719$130.69$355.35K32,959Direct
Filing footnotes · 2
  1. F1The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Lieser on August 11, 2025.
  2. F2Represents the balance of shares of Belden Inc. common stock held in the Belden Retirement Savings Plan as of the date of this filing.
Open on SEC EDGAR
Doug ZinkVP and CAO
4Rule 10b5-1 plan disclosed
Filed Feb 6, 2026Period of report Feb 4, 20260001193125-26-041515
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 6, 2026
Common StockF31,452$133.96$194.51K4,642Direct
SaleFeb 5, 2026
Common StockF3485$126.00$61.11K4,642Direct
Filing footnotes · 7
  1. F1The exercise reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Zink on August 12, 2025.
  2. F2This represents the difference between the number of SARs exercised (1,705) and the number of shares issued as a result of the exercise (485). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($128.57) and the exercise price ($72.73). Additional shares were then withheld to satisfy the Company's tax withholding obligations.
  3. F3The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Zink on August 12, 2025.
  4. F4This represents the difference between the number of SARs exercised (1,579) and the number of shares issued as a result of the exercise (652). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($129.36) and the exercise price ($51.14). Additional shares were then withheld to satisfy the Company's tax withholding obligations.
  5. F5This represents the difference between the number of SARs exercised (1,734) and the number of shares issued as a result of the exercise (800). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($129.36) and the exercise price ($45.11). Additional shares were then withheld to satisfy the Company's tax withholding obligations.
  6. F6Represents the balance of shares of Belden Inc. common stock held in the Belden Retirement Savings Plan as of the date of this filing.
  7. F7The original grant of stock appreciation rights became exercisable in equal portions on the first three anniversaries of the grant date.
Open on SEC EDGAR
Leah TateSVP - HR
4Rule 10b5-1 plan disclosed
Filed Feb 6, 2026Period of report Feb 4, 20260001193125-26-041218
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 4, 2026
Common StockF12,954$130.00$384.02K24,881Direct
Filing footnotes · 2
  1. F1The sale reported was effected pursuant to a Rule 10b5-1 trading plan executed by Ms. Tate on August 11, 2025.
  2. F2Represents the balance of shares of Belden Inc. common stock held in the Belden Retirement Savings Plan as of the date of this filing.
Open on SEC EDGAR
Jonathan C KleinDirector
4
Filed Dec 12, 2025Period of report Dec 11, 20250001193125-25-317207
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 11, 2025
Common Stock3,000$124.19$372.57K8,353Direct
Open on SEC EDGAR
Doug ZinkVP and CAO
4Rule 10b5-1 plan disclosed
Filed Dec 10, 2025Period of report Dec 9, 20250001193125-25-313859
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 9, 2025
Common StockF14,000$125.00$500.00K4,642Direct
Filing footnotes · 2
  1. F1The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Zink on August 12, 2025.
  2. F2Represents the balance of shares of Belden Inc. common stock held in the Belden Retirement Savings Plan as of the date of this filing.
Open on SEC EDGAR
Brian LieserEVP, Solutions
4Rule 10b5-1 plan disclosed
Filed Dec 8, 2025Period of report Dec 4, 20250001193125-25-311352
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 5, 2025
Common StockF61,270$120.00$152.40K29,074Direct
Filing footnotes · 7
  1. F1The exercise reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Lieser on August 11, 2025.
  2. F2Represents the balance of shares of Belden Inc. common stock held in the Belden Retirement Savings Plan as of the date of this filing.
  3. F3This represents the difference between the number of SARs exercised (2,516) and the number of shares issued as a result of the exercise (757). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($120.695) and the exercise price ($53.79). Additional shares were then withheld to satisfy the Company's tax withholding obligations.
  4. F4This represents the difference between the number of SARs exercised (1,210) and the number of shares issued as a result of the exercise (249). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($120.695) and the exercise price ($74.91). Additional shares were then withheld to satisfy the Company's tax withholding obligations.
  5. F5This represents the difference between the number of SARs exercised (1,225) and the number of shares issued as a result of the exercise (264). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($120.695) and the exercise price ($72.73). Additional shares were then withheld to satisfy the Company's tax withholding obligations.
  6. F6The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Lieser on August 11, 2025.
  7. F7The original grant of stock appreciation rights became exercisable in equal portions on the first three anniversaries of the grant date.
Open on SEC EDGAR
Hiran BhadraSVP, Strategy & Technology
4Rule 10b5-1 plan disclosed
Filed Dec 8, 2025Period of report Dec 4, 20250001193125-25-311274
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 5, 2025
Common Stock HoldingF31,600$120.00$192.00K26,119Direct
Filing footnotes · 5
  1. F1The exercise reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Bhadra on August 15, 2025.
  2. F2This represents the difference between the number of SARs exercised (4,847) and the number of shares issued as a result of the exercise (1,600). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($120.695) and the exercise price ($54.89). Additional shares were then withheld to satisfy the Company's tax withholding obligations.
  3. F3The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Bhadra on August 15, 2025.
  4. F4Represents the balance of shares of Belden Inc. common stock held in the Belden Retirement Savings Plan as of the date of this filing.
  5. F5The original grant of stock appreciation rights became exercisable in equal portions on the first three anniversaries of the grant date.
Open on SEC EDGAR
Leah TateSVP - HR
4Rule 10b5-1 plan disclosed
Filed Dec 4, 2025Period of report Dec 3, 20250001193125-25-307844
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 3, 2025
Common StockF12,554$120.00$306.48K27,835Direct
Filing footnotes · 1
  1. F1The sale reported was effected pursuant to a Rule 10b5-1 trading plan executed by Ms. Tate on August 11, 2025.
Open on SEC EDGAR
Brian LieserEVP, Solutions
4Rule 10b5-1 plan disclosed
Filed Dec 4, 2025Period of report Dec 2, 20250001193125-25-307834
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 2, 2025
Common StockF11,713$114.13$195.50K29,074Direct
Filing footnotes · 1
  1. F1The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Lieser on August 11, 2025.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.